No Data
Yuningwei (301166.SZ): has repurchased a total of 0.80% of its shares.
On January 2, Gelonghui announced that, as of December 31, 2024, the company had repurchased a total of 690,700 shares through a share buyback special Account via centralized bidding Trade, accounting for 0.80% of the company's total share capital, with the highest Fill Price being 31 yuan/share and the lowest Fill Price being 24.98 yuan/share, with a total payment amounting to 19.494546 million yuan (excluding transaction fees).
Yuningwei (301166.SZ) terminates the absorption merger of Nanjing Yuningwei with Nanjing Youai.
You Ningwei (301166.SZ) announced that Nanjing You Ningwei (a wholly-owned subsidiary of the company) originally planned to conduct a merger by absorption...
Shareholder Taili Investment and its concerted actions have completed a shareholding reduction of 1.36% in Youniwei (301166.SZ).
Unicore (301166.SZ) announced that the company's shareholder shanghai Entrepreneurship Relay Taili Entrepreneurship Investment Center (Limited Partnership)...
Unigroup Guoxin (301166.SZ): cumulative repurchased 0.49% of shares.
Grant Hui Nov. 1st | Yuninwei (301166.SZ) announced that as of October 31, 2024, the company repurchased a total of 421,700 shares of the company through a special securities account for share repurchases in a centralized auction trading manner, accounting for 0.49% of the total share capital of the company. The highest fill price was 30 yuan/share, and the lowest fill price was 24.98 yuan/share, with a total amount paid of 11,369,227 yuan (excluding transaction costs). The repurchase of shares this time is in compliance with relevant laws, administrative regulations, normative documents, and company share repurchase schemes.
Unionway: 2024 Third Quarter Report
Youniwei (301166.SZ): The net income in the first three quarters was 14.0791 million yuan, a year-on-year decrease of 65.05%.
On October 28, Yuninwei (301166.SZ) announced its third quarter report for 2024, with the company achieving revenue of 0.828 billion yuan for the first three quarters, a 6.60% year-on-year decrease; net income attributable to shareholders of the listed company was 14.0791 million yuan, a 65.05% year-on-year decrease; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -4.0169 million yuan; and basic earnings per share was 0.16 yuan.
Shanghai Universal BiotechLtd (SZSE:301166) Is Reinvesting At Lower Rates Of Return
